FDA advisers vote to oppose Pfizer/BioNTech COVID-19 vaccine booster

France Nouvelles Nouvelles

FDA advisers vote to oppose Pfizer/BioNTech COVID-19 vaccine booster
France Dernières Nouvelles,France Actualités
  • 📰 Reuters
  • ⏱ Reading Time:
  • 19 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 11%
  • Publisher: 97%

A panel of outside advisers to the U.S. Food and Drug Administration on Friday voted against approval of a booster dose of the Pfizer Inc /BioNTech SE COVID-19 vaccine for people aged 16 and older.

A vial labelled with the Pfizer-BioNTech coronavirus disease vaccine is seen in this illustration picture taken March 19, 2021.

Dado Ruvic/IllustrationSept 17 - A panel of outside advisers to the U.S. Food and Drug Administration on Friday voted against approval of a booster dose of the Pfizer IncReporting by Manojna Maddipatla in Bengaluru; Editing by Leslie AdlerSubscribe for our daily curated newsletter to receive the latest exclusive Reuters coverage delivered to your inbox.

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

Reuters /  🏆 2. in US

France Dernières Nouvelles, France Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

COVID-19 Vaccines Won’t Affect Your Sexual Performance, but COVID-19 MightCOVID-19 Vaccines Won’t Affect Your Sexual Performance, but COVID-19 MightJust in case you were wondering.
Lire la suite »

FDA Questions Need For Pfizer Covid-19 Booster Shot Ahead Of Vote FridayFDA Questions Need For Pfizer Covid-19 Booster Shot Ahead Of Vote FridayScientists at the FDA said Pfizer’s Covid-19 vaccine seems to last long enough that a booster shot may not add much protection
Lire la suite »

FDA Questions Need For Pfizer Covid-19 Booster Shot Ahead Of Vote FridayFDA Questions Need For Pfizer Covid-19 Booster Shot Ahead Of Vote FridayScientists at the FDA said Pfizer’s Covid-19 vaccine seems to last long enough that a booster shot may not add much protection
Lire la suite »

FDA panel is first key test for Biden COVID-19 booster planFDA panel is first key test for Biden COVID-19 booster planGovernment advisers are debating whether to recommend extra doses of the Pfizer vaccine, a key step toward the Biden administration's plan to dispense COVID-19 booster shots. Scientists have been divided over the need for boosters and who should get them.
Lire la suite »

FDA Panel Weighs Covid-19 Booster Shots as Health Officials Debate NeedFDA Panel Weighs Covid-19 Booster Shots as Health Officials Debate NeedThe Biden administration’s push to introduce widespread vaccine boosters faces a test as a Food and Drug Administration advisory panel meets to weigh evidence on the extra shots, a topic that has divided federal health officials.
Lire la suite »

1 in 7 Dropped Friends Over COVID-19 Vaccine Views: Survey1 in 7 Dropped Friends Over COVID-19 Vaccine Views: SurveyAbout 1 in 7 Americans have ended friendships during the past year due to divided views over COVID-19 vaccines, according to a new survey.
Lire la suite »



Render Time: 2025-04-04 13:35:27